Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery

Anticancer Research

Volumn 18, Issue 6 A, 1998, Pages 4443-4448

  Shibata, Toshiyuki ^a   Yamashita, Tetsurou ^b   Suzuki, Kazufumi ^c   Takeichi, Noritoshi ^d   Micallef, Mark ^d   Hosokawa, Masuo ^d   Kobayashi, Hiroshi ^d   Murata, Masaru ^a   Arisue, Makoto ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Keiyuukai Sapporo Hospital   (Japan)

^c Yamanote Suzuki Dental Clinic   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cryo immunology; Cryosurgery; Double graft system; Metastasis

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CRYOSURGERY; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; LUNG METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

ANIMALS; CRYOSURGERY; FEMALE; FIBROSARCOMA; LUNG NEOPLASMS; METHYLCHOLANTHRENE; RATS; RATS, WISTAR; SARCOMA, EXPERIMENTAL;

EID: 0032436817     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Yamashita T, Hayakawa K, Hosokawa M, Kodama T, Inoue N, Tomita K, Kobayashi H: Enhanced tumor metastases in rats following cryosurgery of primary tumor. Gann 73: 222-228, 1982.
2. Hayakawa K, Yamashita T, Suzuki K, Tomita K, Hosokawa M, Kodama T, Kobayashi H: Comparative immunological studies in rats following cryosurgery and surgical excision of 3-methylcholanthrene-induced primary autochthonous tumors. Gann 73: 462-469, 1982.
3. Shibata T, Suzuki K, Yamashita T, Takeichi N, Micallef M, Hosokawa M, Kobayashi H, Arisue M: Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery. Anticancer Res 18: 1998. in press.
4. Akiyama J, Kawamura T, Gotohda E, Yamada Y, Hosokawa M, Kodama T, Kobayashi H: Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes. Cancer Res 37: 3042-3045, 1977.
5. Soanes WA, Ablin RJ, Gonder MI: Remission of metastatic lesion following cryosurgery prostatic cancer: Immunological considerations. J Urol 104: 154-159, 1970.
6. Ablin RJ, Soanes WA, Gonder MJ: Prospects for cryoimmunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology 8: 271- 279, 1971.
7. Gursel E, Roberts M, Veenema RJ: Regression of prostatic cancer following sequential cryotherapy to the prostate. J Urol 108: 928-935, 1972.
8. Ablin RJ: Serum proteins in prostatic cancer. IV. Reduction of the suppressive (blocking?) properties of serum on in vitro parameters of cell-mediated immunologic responsiveness following cryosurgery. Urol. Int 32: 65-73, 1977.
9. Kimura H: Comparative immunological studies on cryosurgery and surgical operation. using Moloney murine sarcoma virus-induced primary tumors in BALB/c mice. Gann 69: 507-515, 1978.
10. Wing MG, Rogers K, Jacob G, Rees RC: Characterization of suppresser cells generated following cryosurgery of an HSV-2-induced fibrosarcoma. Cancer Immunol Immunother 26: 169-175, 1988.
11. Wing MG, Goepel JR, Jacob G, Rees RC, Rogers K: Comparison of excision versus cryosurgery of an HSV-2-induced fibrosarcoma. I.Survival, extent of metastatic disease and host immunocompetence following surgery. Cancer Immunol Immunother 26: 161-168, 1988.
12. Ebina T, Kohya H, Yamaguchi T, Ishida N: Antimetastatic effect of biological response modifiers in the "double grafted tumor system". Jpn J Cancer Res 77: 1034-1042, 1986.
13. Ebina T, Kohya H: Antitumor effector mechanism at distant site in the double grafted tumor system of PSK, a protain-bound polysaccharide preparation. Jpn J Cancer Res 79: 975-964, 1988.
14. Chiba I, Oikawa T, Naiki M et al: Enhanced immunogenicity of the cultured rat fibrosarcoma KMT-17 by cultivation in a low concentration of fetal calf serum. Cancer Res 47: 1815-1819, 1987.
15. Chiba I, Jin R Hamada J-I, Hosokawa M, Takeichi N, Kobayashi H: Growth-associated shedding of a tumor antigen (CE7) detected by a monoclonal antibody. Cancer Res 49: 395-397, 1989.
16. Micallef M, Shibata T, Hosokawa M, Kobayashi H: Bleomycin but not its derivatives inhibits the in vivo shedding of a rat tumor-associated antigen. Anti-Cancer Drugs 3: 659-664, 1992.
17. Shibata T, Micallef M, Chiba I, Hosokawa M, Kobayashi H: Modulation of the shedding of a rat tumor-associated antigen by growth regulation and anti-cancer drugs. Anti-Cancer Drugs 4: 657-664, 1993.
18. Shibata T, Hosokawa M, Micallef M, Ren J, Chiba I, Takeichi N, Kobayashi H: Modulation of the rat tumor-associated shedding antigen (CE7) and augmentation of immunogenicity by irradiation. Anticancer Res 16: 99-104, 1996.
19. Shibata T, Hosokawa M, Micallef M, Chiba I, Mizukoshi T, Kalo M, Takeichi N, Kobayashi H: Enhancement of tumor antigen expression and inhibition of pulmonary metastasis of rat fibrosarcoma cells by local radiotherapy. Anticancer Res 17: 317-322, 1997.
20. Shibata T, Micallef M, Chiba I, Arisue M, Hosokawa M, Okada F, Takeichi N, Kobayashi H: Enhancement of tumor associated antigen expression during the regression phase of xenogenized tumor cell growth in vivo. Anticancer Res 17: 2135-2140, 1997.